Published in Arch Immunol Ther Exp (Warsz) on January 01, 2002
Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol (2010) 0.95
Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconj J (2008) 0.95
Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immun (2009) 0.92
Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med Microbiol Immunol (2007) 0.91
A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice. Vaccine (2009) 0.87
Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis. Vaccine (2007) 0.87
Lactoferrin modulation of antigen-presenting-cell response to BCG infection. Postepy Hig Med Dosw (Online) (2007) 0.84
Lactoferrin Augmentation of the BCG Vaccine Leads to Increased Pulmonary Integrity. Tuberc Res Treat (2011) 0.81
Lactoferrin directly scavenges hydroxyl radicals and undergoes oxidative self-degradation: a possible role in protection against oxidative DNA damage. Int J Mol Sci (2014) 0.78
Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice. Microbes Infect (2014) 0.78
Innate endogenous adjuvants prime to desirable immune responses via mucosal routes. Protein Cell (2014) 0.75
Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology. Mediators Inflamm (2015) 0.75
Neolactoferrin as a stimulator of innate and adaptive immunity. Acta Naturae (2013) 0.75
Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank. Pharmacol Rep (2010) 1.25
Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs (2009) 1.14
Effects of bacteriophages on free radical production and phagocytic functions. Med Microbiol Immunol (2006) 0.97
A new class of isoxazole derivatives: the M 1-9 series of compounds with immunotropic activity. Acta Pol Pharm (2008) 0.87
Normalization of peripheral blood cell composition by lactoferrin in cyclophosphamide-treated mice. Med Sci Monit (2004) 0.86
The adjuvant activity of lactoferrin in the generation of DTH to ovalbumin can be inhibited by bovine serum albumin bearing alpha-D-mannopyranosyl residues. Cell Mol Biol Lett (2002) 0.86
Synthesis and pharmacological screening of derivatives of isoxazolo[4,5-d]pyrimidine. Eur J Med Chem (2008) 0.84
The immunosuppressive activity and solution structures of ubiquitin fragments. Biopolymers (2009) 0.84
Effect of phage therapy on the turnover and function of peripheral neutrophils. FEMS Immunol Med Microbiol (2002) 0.83
[The role of lactoferrin in the proper development of newborns]. Postepy Hig Med Dosw (Online) (2005) 0.81
Synthesis and selected immunological properties of substituted quino[3,2-b]benzo[1,4]thiazines. Eur J Med Chem (2013) 0.80
Milk-derived proteins and peptides in clinical trials. Postepy Hig Med Dosw (Online) (2013) 0.79
Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression. J Biotechnol (2013) 0.79
The effects of lactoferrin on myelopoiesis: can we resolve the controversy? Postepy Hig Med Dosw (Online) (2007) 0.79
Synthesis and immunosuppressive activity of cyclolinopeptide A analogues containing homophenylalanine. Eur J Med Chem (2009) 0.78
Lactoferrin inhibits the growth of nasal polyp fibroblasts. Pharmacol Rep (2011) 0.78
Immunosuppressive activity of an isoxazolo[5,4-e]triazepine--compound RM33. I. Effects on the humoral and cellular immune response in mice. Pharmacol Rep (2005) 0.78
Amino-terminal dimerization of peptides on the solid support. Synthesis and biological activity of the immunosuppressive HLA-DR fragments linked by poly(ethylene glycol)s. Bioconjug Chem (2006) 0.78
New lead structures in the isoxazole system: relationship between quantum chemical parameters and immunological activity. Acta Pol Pharm (2014) 0.78
Immunosuppressory activity of ubiquitin fragments containing retro-RGD sequence. Biopolymers (2004) 0.78
Cyclolinopeptide derivatives modify methotrexate-induced suppression of the humoral immune response in mice. Eur J Med Chem (2011) 0.77
A novel immunosuppressory peptide originating from the ubiquitin sequence. Peptides (2011) 0.77
Synthesis, conformational analysis and immunological activity of beta3Phe-substituted Cyclolinopeptide A analogues. J Pept Sci (2009) 0.76
Dimeric analogs of immunosuppressive decapeptide fragment of ubiquitin. J Pept Sci (2012) 0.76
New analogue of cyclolinopeptide B modified by amphiphilic residue of alpha-hydroxymethylmethionine. Acta Biochim Pol (2004) 0.75
New amides of 5-acylamino-3-methyl-4-isothiazolecarboxylic acid and their immunotropic activity. Arch Pharm (Weinheim) (2005) 0.75
Synthesis, immunological activity and computational study of 5-amino-3-methyl-4-isoxazolecarboxylic acid semicarbazides and thiosemicarbazides. Acta Pol Pharm (2008) 0.75
Reactions of N(3) -substituted amidrazones with cis-1,2-cyclohexanedicarboxylic anhydride and biological activities of the products. Arch Pharm (Weinheim) (2012) 0.75
Synthesis and immunomodulatory activites of new 5-hydrazino-3-methyl-4-isothiazolecarboxylic acid ethyl esters. Acta Pol Pharm (2009) 0.75
Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potency. Peptides (2004) 0.75
Structure and immunological activity of disubstituted thiosemicarbazide isoxazole derivative. Acta Pol Pharm (2004) 0.75
Search for new lead structures in the isoxazole heterocyclic system. Acta Pol Pharm (2003) 0.75
Threonine at position 6 is not essential for the immunosuppressive activity of HLA-DQ(beta164-172)-hexapeptide. Mol Immunol (2004) 0.75
Characterization of the human lactoferrin (HLF) cell line HLFK1, generated in CBA mice. Cell Mol Biol Lett (2003) 0.75
The immunoregulatory effects of edeine analogues in mice. Cell Mol Biol Lett (2006) 0.75
New derivatives of 5-amino-3-methyl-4-isothiazolecarboxylic acid and their immunological activity. Acta Pol Pharm (2007) 0.75
Antimicrobial properties of substituted quino[3,2-b]benzo[1,4]thiazines. Pol J Microbiol (2014) 0.75
Synthesis and immunosuppressive activity of new cyclolinopeptide A analogs modified with beta-prolines. J Pept Sci (2008) 0.75
The synthesis, physicochemical properties and immunological activity of 5-amino-3-methylisoxazolo[5,4-d]4-pyrimidinone derivatives. Cell Mol Biol Lett (2005) 0.75
Synthesis, crystal structure and biological activities of a novel amidrazone derivative and its copper(II) complex--a potential antitumor drug. J Inorg Biochem (2012) 0.75
Synthesis, immunological activity and theoretical study of new 5-substituted 3-methylisoxazole[5,4-d] 1,2,3-triazin-4-one derivatives. Acta Pol Pharm (2003) 0.75
7-amino-3,5-dimethylisoxazole [5,4-e] [1,3,4]-triazepin-4-one- a potential new lead structure: its structure, physicochemical properties and biological activity. Acta Pol Pharm (2004) 0.75
Search for new lead structures for low-molecular-weight immune response modifiers. Acta Pol Pharm (2004) 0.75